Windlas Biotech Buyback 2026 Record Date, Price & Ratio Details

Windlas Biotech Buyback 2026 details: The Windlas Biotech Buyback open date is 2026. Windlas Biotech Buyback record date is 2026. The investor should buy the Windlas Biotech Buyback shares before the record date to get eligibility for the buyback.

Windlas Biotech Buyback 2026

Windlas Biotech Buyback of ₹[.] crores approved by the board of directors at the meeting held on April 17, 2026. Windlas Biotech Buyback will be done via the Tender Offer route through the stock exchange mechanism. The board of directors of the company approved the buyback by the Company of its fully paid-up equity shares having a face value of ₹[.] each equity share at a price of ₹[.] per Equity Share and for an aggregate amount not exceeding ₹[.] crores from the shareholders. Check out Windlas Biotech Buyback 2026 details below:


Windlas Biotech Buyback About us

To be updated soon

Windlas Biotech Buyback History

  • N/A

Windlas Biotech Buyback 2026 Dates

Buyback Meeting Date:April 17, 2026
Buyback Announcement Date:April 17, 2026
Buyback Record Date:2026
Last Date to Buy Shares:2026
Buyback Open Date:2026
Buyback Close Date:2026
Finalization of Buyback Acceptance:2026

Windlas Biotech Buyback 2026 Offer Details

Windlas Biotech Buyback of [.] equity shares at a price of ₹[.] per equity share. The buyback offers not to exceed ₹[.] crores of the total buyback offer size.

Offer Amount:₹[.] Crores
Number of Shares:[.] Equity Shares
Face Value:₹[.] per equity share
Buyback Price:₹[.] per equity share
Listing:[.]
Buyback Type:Tender Offer
Letter of Offer:Click Here

Windlas Biotech Buyback 2026 Acceptance Ratio

The investor should buy around [.] shares at a current market price of ₹[.] (as of date). The calculation will be ₹2,00,000 / ₹[.] buyback price = [.] shares.

Acceptance RatioInvestmentShares BuybackProfit
33%₹[.][.]₹[.]
50%₹[.][.]₹[.]
75%₹[.][.]₹[.]
100%₹[.][.]₹[.]

Windlas Biotech Financial Report

₹ in Crores
YearRevenueExpensePAT
2023₹523.05₹465.99₹42.64
2024₹644.42₹567.40₹58.14
2025₹777.52₹698.13₹60.65

How to Participate in Windlas Biotech Buyback 2026

The investors, who have Windlas Biotech Buyback shares in their Demat Account as of the Record Date, are eligible for the buyback scheme. Eligible Shareholders can participate in the Windlas Biotech Buyback 2026 scheme as per the opening form by selling their shares. The payment will be made as per the Windlas Biotech Buyback, with shares accepted by the company under the Windlas Biotech Buyback scheme.

Windlas Biotech Buyback 2026 Registrar

MUFG Intime India Pvt. Ltd.
Phone:
Email:
Website: https://in.mpms.mufg.com/Offer/Default.aspx

Windlas Biotech Buyback 2026 Lead Managers

  • To be updated soon

Windlas Biotech Company Address

Windlas Biotech Limited
40/1,
Mohabewala Industrial Area,
Dehradun-248110,
Uttarakhand, India
Phone:
Email:
Website: https://windlas.com/

Windlas Biotech Buyback 2026 FAQs


When is Windlas Biotech Buyback 2026 Record Date?

Windlas Biotech Buyback 2026 record date is 2026.

When is Windlas Biotech Buyback 2026 Open Date?

Windlas Biotech Buyback 2026 open date is 2026.

What is Windlas Biotech Buyback 2026 Price?

The company has fixed the price at ₹[.] per share.

How to apply for Windlas Biotech Buyback 2026?

As per the record date you need to have Windlas Biotech Buyback shares in your Demat Account. You can participate in buyback after having the stock in your Account.

Table of Contents

Picture of Jagat Joshi

Jagat Joshi

Founder of IPOWatch, brings nearly 15 years of experience in IPO analysis and market research. He provides complete coverage of upcoming IPOs, subscription trends, grey market premiums (GMP), and post-listing performance, along with easy-to-understand reviews, insights, and analysis. In his working journey, he has worked with various platforms and received expertise in stock market analysis and primary markets.
Picture of Jagat Joshi

Jagat Joshi

Disclaimer: This content is provided strictly for educational and informational purposes. The securities or investments mentioned are not to be considered as investment advice or recommendations. The Investors are advised to do their own research or connect with a financial advisor before making any investment decisions.

Leave a Reply

Your email address will not be published. Required fields are marked *